Dermal Toxicity of 8-Methoxypsoralen Administered (by Gavage) To Hairless Mice Irradiated With Long-Wave Ultraviolet Light
- 1 November 1977
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 69 (5) , 451-457
- https://doi.org/10.1111/1523-1747.ep12511300
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- PHOTOCHEMOTHERAPY (PUVA) AND PSORIASIS: COMPARISON OF 8-MOP AND 8-MQP/5-MOPInternational Journal of Dermatology, 1976
- EFFECTS OF 8‐METHOXYPSORALEN‐INDUCED PHOTOTOXIC EFFECTS ON MAMMALIAN EPIDERMAL MACROMOLECULE SYNTHESIS IN VIVOPhotochemistry and Photobiology, 1975
- Studies on the role of C-type viruses in the development of epithelial tumors induced with DMBAArchives of Dermatological Research, 1975
- Testing Drug Phototoxicity in Mice*Journal of Investigative Dermatology, 1967
- Photosensitization by 8-Methoxypsoralen11From the Department of Environmental Medicine, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland.Journal of Investigative Dermatology, 1961
- Erythema and Tumor Formation in Methoxsalen-Treated Mice Exposed to Fluorescent LightArchives of Dermatology, 1960
- Ultra-Violet Carcinogenesis in Albino and Pigmented Mice Receiving Furocoumarins: Psoralen and 8-MethoxypsoralenNature, 1959
- Part V: Clinical Applications of Psoralens, and Related Materials: Methoxsalen in Ultraviolet Carcinogenesis in the MouseJournal of Investigative Dermatology, 1959
- Part V: Clinical Applications of Psoralens, and Related Materials: Modification of Ultraviolet Carcinogenesis by Photoactive Agents1Journal of Investigative Dermatology, 1959
- The Wave Length Effect Upon Erythemal and Carcinogenic Response in Psoralen Treated Mice11From the Department of Biochemistry, The University of Texas M.D. Anderson Hospital and Tumor Institute and the Departments of Biochemistry and Dermatology, Baylor University College of Medicine, Houston, Texas. Supported by grants from the Robert A. Welch Foundation, Humble Oil and Refining Company and the National Cancer Institute (NCI 2620), U. S. Department of Health, Education and Welfare.Journal of Investigative Dermatology, 1958